霍奇金淋巴瘤治疗后的第二恶性风险

{"title":"霍奇金淋巴瘤治疗后的第二恶性风险","authors":"M. Schaapveld, D. Hodgson, F. V. van Leeuwen","doi":"10.1007/978-3-319-12505-3_24","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":162602,"journal":{"name":"Hodgkin Lymphoma","volume":"32 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Second Malignancy Risk After Treatment of Hodgkin Lymphoma\",\"authors\":\"M. Schaapveld, D. Hodgson, F. V. van Leeuwen\",\"doi\":\"10.1007/978-3-319-12505-3_24\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":162602,\"journal\":{\"name\":\"Hodgkin Lymphoma\",\"volume\":\"32 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hodgkin Lymphoma\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/978-3-319-12505-3_24\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hodgkin Lymphoma","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/978-3-319-12505-3_24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}